Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/17/1992 | EP0490249A1 Process for the enzymatic preparation of GRF(1-44)NH2 |
06/17/1992 | EP0489837A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
06/17/1992 | EP0489830A1 Expression of alpha-macroglobulins |
06/17/1992 | EP0489822A1 Abo genotyping |
06/17/1992 | EP0489780A1 Fusion proteins, their preparation and use |
06/17/1992 | EP0485608A4 Method for obtaining polypeptides in a cell-free translation system |
06/17/1992 | EP0484411A4 Prevention of internal initiation |
06/17/1992 | EP0479922A4 Monoclonal antibodies to c-reactive protein |
06/17/1992 | EP0215131B1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma |
06/16/1992 | US5122600 Using a carrier of specific particle size and one which does not absorb protein |
06/16/1992 | US5122594 Having specific arginines replaced by glutamine and/or serine |
06/16/1992 | US5122466 Ballistic transformation of conifers |
06/16/1992 | US5122464 Method for dominant selection in eucaryotic cells |
06/16/1992 | US5122463 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor |
06/16/1992 | US5122458 Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells |
06/16/1992 | US5122457 Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase |
06/16/1992 | US5122449 Complexing antigen with labeled antibodies; immunoassay |
06/16/1992 | CA1303534C Human anti-rh(d) monoclonal antibodies |
06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
06/16/1992 | CA1303532C Determination of fibrin using fibrin-specific antibodies |
06/16/1992 | CA1303531C Choriocarcinoma monoclonal antibodies and antibody panels |
06/16/1992 | CA1303529C Human interferon- _polypeptide derivative |
06/16/1992 | CA1303524C Drug-monoclonal antibody conjugates |
06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
06/14/1992 | WO1992010577A1 Multisite integration cassette for the genome of a yeast |
06/14/1992 | WO1992010576A1 Fusion polypeptides |
06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
06/14/1992 | CA2098304A1 Multisite integration cassette for the genome of a yeast |
06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
06/14/1992 | CA2094512A1 Fusion polypeptides |
06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
06/11/1992 | WO1992009701A1 Analytical tracers for cancer, particularly malignant breast cancer |
06/11/1992 | WO1992009699A1 Monoclonal antibody for use in diagnosing alzheimer's disease, hybridoma secreting said antibody and preparation method therefor |
06/11/1992 | WO1992009698A1 Expression of pace in host cells and methods of use thereof |
06/11/1992 | WO1992009695A1 Structural proteins from artificial genes |
06/11/1992 | WO1992009693A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
06/11/1992 | WO1992009623A1 METHOD FOR PREPARING A PROTEIN COMPRISING AT LEAST ONE INTRAMOLECULAR DISULPHIDE BOND BY OXIDATION, AT A pH OF LESS THAN 5.0, OF THE REDUCED RECOMBINANT PROTEIN |
06/11/1992 | WO1992009617A1 Cell stress transcriptional factors |
06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/11/1992 | WO1992009200A1 Novel polypeptides for promoting cell attachment |
06/11/1992 | DE4139840A1 Compsns. contg. antigen from cell-associated protein of H. pylorus - useful for sensitive selective detection of antibodies with less false positives and negatives |
06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
06/11/1992 | CA2073860A1 Analytical tracers for cancer, particularly malignant breast cancer |
06/11/1992 | CA2073564A1 Method for preparing a protein comprising at least one intramolecular disulphide bond by oxidation, at a ph of less than 5.0, of the reduced recombinant protein |
06/11/1992 | CA2057269A1 Process for the enzymatic preparation of grf(1-44)nh2 |
06/10/1992 | EP0489718A1 Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
06/10/1992 | EP0489711A2 Method for producing human growth hormone |
06/10/1992 | EP0489149A1 Probes for detecting mutant p53 |
06/10/1992 | EP0489113A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
06/10/1992 | EP0489062A1 Bone-specific protein |
06/10/1992 | EP0489058A1 Cystic fibrosis gene |
06/10/1992 | EP0174367B1 Hosts and methods for producing recombinant products in high yields |
06/10/1992 | CN1016967B Process for purifying human physiologically active polypeptide |
06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
06/09/1992 | US5120642 Medical diagnosis |
06/09/1992 | US5120536 Pure cultures from which crystalline parasporal proteins are obtained |
06/08/1992 | WO1992010575A1 Bifunctional inhibitors of thrombin and platelet activation |
06/08/1992 | WO1992010572A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
06/08/1992 | WO1992010571A1 Human dopamine d4 receptor and its uses |
06/08/1992 | CA2097509A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
06/08/1992 | CA2096545A1 Bifunctional inhibitors of thrombin and platelet activation |
06/05/1992 | WO1992010562A1 Ganoderma lucidium iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity |
06/05/1992 | CA2031455A1 Method for producing hybridoma antibodies and their use |
06/04/1992 | WO1992009613A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
06/04/1992 | DE4038189A1 Epididymis-specific DNA sequences |
06/04/1992 | CA2097416A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
06/03/1992 | EP0488622A2 Squamous cell carcinoma-like immunoreactive antigen from human female urine |
06/03/1992 | EP0488589A1 Process for producing kappa-casein glycomacropeptides |
06/03/1992 | EP0488479A1 DNA sequences, recombinant DNA molecules and processes for producing swine growth hormone-like polypeptides |
06/03/1992 | EP0488470A1 Method for the production of antibodies |
06/03/1992 | EP0488279A2 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
06/03/1992 | EP0488277A1 Antibody reactive to hamster immunoglobulins |
06/03/1992 | EP0488224A2 Fermentationproduct of a Verticimonosporium strain and feed additivs containing a linear peptide |
06/03/1992 | EP0488196A2 HST-2, a member of the heparin binding growth factor family |
06/03/1992 | EP0488170A1 Cell-free receptor binding tests, their production and use |
06/03/1992 | EP0488061A2 The MAC-1 binding site of ICAM-1 |
06/03/1992 | EP0487718A1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety |
06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
06/03/1992 | EP0487618A1 Thylakoid targeting sequence |
06/03/1992 | EP0487610A1 Prohormone cleavage site blocking antibody |
06/03/1992 | EP0452391A4 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
06/03/1992 | EP0371049B1 Method for the diagnosis of infections with detection of lipopolysaccharide antigens |
06/03/1992 | EP0370036B1 Modified factor vii/viia |
06/03/1992 | EP0202260B1 Improved antigenic preparation |
06/03/1992 | CN1061623A The ciliary neurotrophic factor receptor |
06/02/1992 | US5118790 Analogs of hirudin |
06/02/1992 | US5118784 High strength, radiation transparent, elastic; films, fibers |
06/02/1992 | US5118668 Peptide having sequence of appotinin where in one or more amino acids are replaced at position 15,16,17,18 34-39 and 52. by naturally occuring amino acid useful for hyperfibrinolytic or traumatic hemorrhage |
06/02/1992 | US5118622 Polypeptide possessing isoamylase activity, and its use in the hydrolysis of amylaceous substances |
06/02/1992 | US5118618 Dimethylglycine enhancement of antibody production |
06/02/1992 | US5118617 Saf polypeptide, gene coding therefor, saf promoter and expression methods for expressing foreign dna sequences in streptomyces |
06/02/1992 | US5118616 Method of producing substances in living silkworms |
06/02/1992 | CA1302652C Method for purifying granulocyte-macrophage colony stimulating factor |